346 related articles for article (PubMed ID: 17525649)
1. Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis.
Kim MK; Lee SM; Lee JL; Chung TY; Kim YH; Wee WR; Lee JH
Cornea; 2007 Jun; 26(5):546-51. PubMed ID: 17525649
[TBL] [Abstract][Full Text] [Related]
2. [Clinical management of severe ocular surface disease].
Stoiber J; Grabner G
Klin Monbl Augenheilkd; 2005 Jul; 222(7):533-51. PubMed ID: 16034721
[TBL] [Abstract][Full Text] [Related]
3. The Boston Keratoprosthesis in severe ocular trauma.
Harissi-Dagher M; Dohlman CH
Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
[TBL] [Abstract][Full Text] [Related]
4. The Boston keratoprosthesis in Stevens-Johnson syndrome.
Sayegh RR; Ang LP; Foster CS; Dohlman CH
Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
[TBL] [Abstract][Full Text] [Related]
5. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
6. Boston type 1 keratoprosthesis: the university of california davis experience.
Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
[TBL] [Abstract][Full Text] [Related]
7. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
8. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
9. Seoul-type keratoprosthesis: preliminary results of the first 7 human cases.
Kim MK; Lee JL; Wee WR; Lee JH
Arch Ophthalmol; 2002 Jun; 120(6):761-6. PubMed ID: 12049581
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of MICOF keratoprosthesis in the end stage of autoimmune dry eyes: an experience in China.
Huang Y; Dong Y; Wang L; Du G; Yu J; Song J; Chiang HH
Br J Ophthalmol; 2012 Jan; 96(1):28-33. PubMed ID: 21454379
[TBL] [Abstract][Full Text] [Related]
11. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
[TBL] [Abstract][Full Text] [Related]
12. Boston type 1 keratoprosthesis outcomes in ocular burns.
Magalhães FP; Hirai FE; de Sousa LB; de Oliveira LA
Acta Ophthalmol; 2013 Sep; 91(6):e432-6. PubMed ID: 23406295
[TBL] [Abstract][Full Text] [Related]
13. [25 years Cardona keratoprosthesis after severe chemical eye burns--long-term outcome of 4 eyes].
Jähne MG
Klin Monbl Augenheilkd; 2000 Apr; 216(4):191-6. PubMed ID: 10820703
[TBL] [Abstract][Full Text] [Related]
14. Modified osteo-odonto keratoprosthesis--the Indian experience--results of the first 50 cases.
Iyer G; Pillai VS; Srinivasan B; Falcinelli G; Padmanabhan P; Guruswami S; Falcinelli G
Cornea; 2010 Jul; 29(7):771-6. PubMed ID: 20489578
[TBL] [Abstract][Full Text] [Related]
15. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis.
Durand ML; Dohlman CH
Cornea; 2009 Sep; 28(8):896-901. PubMed ID: 19654525
[TBL] [Abstract][Full Text] [Related]
16. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
Kang JJ; de la Cruz J; Cortina MS
Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
[TBL] [Abstract][Full Text] [Related]
17. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
18. Keratoprosthesis: a 12-year follow-up.
Girard LJ; Hawkins RS; Nieves R; Borodofsky T; Grant C
Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1977; 83(2):252-67. PubMed ID: 878136
[TBL] [Abstract][Full Text] [Related]
19. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
[TBL] [Abstract][Full Text] [Related]
20. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis.
Cade F; Grosskreutz CL; Tauber A; Dohlman CH
Cornea; 2011 Dec; 30(12):1322-7. PubMed ID: 22001817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
